Aortic Arch Syndromes: Clinical Trials

9 trials for Aortic Arch Syndromes, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 recruiting, 3 not yet recruiting, 2 unknown. 9 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 49Recruiting 4, Not yet recruiting 3, Unknown 2

Follow Aortic Arch Syndromes: new trials by email Literature Review of Aortic Arch Syndromes trials Research Report on Aortic Arch Syndromes

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of Vunakizumab and Ivarmacitinib in the Treatment of Active Takayasu's Arteritis
Vanakizumab, Ivarmacitinib, Prednisone - Takayasu Arteritis (TAK)
Phase 4Not yet recruitingChinese SLE Treatment And Research Group1802026-04-012026-03-05
Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases
Dengue 1,2,3,4 (attenuated) vaccine - Rheumatoid Arthritis (RA), Juvenile Idiopathic Arthritis (JIA)
Phase 4RecruitingUniversity of Sao Paulo General Hospital4772026-03-162026-07-20
Effect of Pirfenidone on TA Fibrosis
Pirfenidone Capsules, Placebo - Takayasu Arteritis
Phase 4Not yet recruitingShanghai Zhongshan Hospital922025-12-202026-01-08
The Efficacy and Safety of Deucravacitinib in Takayasu's Arteritis
Deucravacitinib, Adalimumab - Takayasu Arteritis (TAK)
Phase 4Not yet recruitingChinese SLE Treatment And Research Group502025-06-152025-06-10
A Randomized, Controlled, Open-label, Multicenter Clinical Trial Comparing the Efficacy and Safety of a Precision Treatment Regimen Based on Clinical-molecular Phenotypes with a Conventional Treatment Regimen in the Treatment of Patients with Active Takayasu's Arteritis
Prednisone, Methotrexate, Tocilizumab - Takayasu Arteritis
Phase 4RecruitingShanghai Zhongshan Hospital1242024-06-282024-10-17
Comparison of Adalimumab and Tofacitinib in the Treatment of Active Takayasu Arteritis
Adalimumab Injection, Tofacitinib 5 MG - Takayasu Arteritis
Phase 4UnknownChinese SLE Treatment And Research Group1002022-01-052023-07-24
Comparison of Tofacitinib and Methotrexate in Takayasu's Arteritis
Tofacitinib, Methotrexate - Takayasu Arteritis
Phase 4RecruitingShanghai Zhongshan Hospital762021-11-012024-10-15
A Pilot Study in Severe Patients With Takayasu Arteritis.
Tocilizumab, Adalimumab - Takayasu Arteritis, Tocilizumab
Phase 4RecruitingShanghai Zhongshan Hospital402020-03-012021-08-10
Efficiency of Methotrexate and Tofacitinib in Mild and Moderate Patients
Methotrexate Tablets, Tofacitinib tablet - Takayasu Arteritis, Methotrexate
Phase 4UnknownShanghai Zhongshan Hospital1302020-03-012020-06-12

Narrower conditions

Takayasu Arteritis (9)  ·  Antiphospholipid Syndrome (1)  ·  Arthritis, Juvenile (1)  ·  Arthritis, Psoriatic (1)  ·  Arthritis, Rheumatoid (1)  ·  Axial Spondyloarthritis (1)  ·  Fibrosis (1)  ·  Granulomatosis with Polyangiitis (1)  ·  Inflammation (1)  ·  Inhibition, Psychological (1)  ·  Lupus Erythematosus, Systemic (1)  ·  Microscopic Polyangiitis (1)  ·  Myositis (1)  ·  Recurrence (1)  ·  Scleroderma, Systemic (1)

Broader conditions

Aortic Diseases (9)  ·  Arteritis (9)  ·  Cardiovascular Diseases (9)  ·  Skin Diseases (9)  ·  Skin Diseases, Vascular (9)  ·  Skin and Connective Tissue Diseases (9)  ·  Vascular Diseases (9)  ·  Vasculitis (9)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Ankylosis (1)  ·  Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (1)  ·  Arthritis (1)  ·  Autoimmune Diseases (1)

Interventions

Adalimumab (4)  ·  tofacitinib (4)  ·  Methotrexate (3)  ·  Prednisone (2)  ·  tocilizumab (2)  ·  Glucocorticoids (1)  ·  Vaccines (1)  ·  deucravacitinib (1)  ·  ivarmacitinib (1)  ·  pirfenidone (1)

Sponsors

Shanghai Zhongshan Hospital (5)  ·  Chinese SLE Treatment And Research Group (3)  ·  University of Sao Paulo General Hospital (1)

Countries

China (7)  ·  Brazil (1)

Top investigators

Lindi Jiang, PhD (3)  ·  Lindi Jiang, Ph.D., M.D. (1)  ·  Xiaofeng Zeng, MD (1)  ·  Xinping Tian, MD (1)

Results publications

PMID 37540159